Bio.Me S. boulardii 60 Capsules
- Dairy Free
- Gluten Free
- Stevia Free
- GMP
- Non GMO
Bio.Me S. boulardii 60 Capsules
S. boulardii is a non-pathogenic yeast which supports the gastrointestinal microbiome. S. boulardii may protect the gastrointestinal mucosa and aid in the production of secretory IgA – part of our innate immune response. This strain is the most studied for its efficiency in the prevention of antibiotic-associated diarrhoea. S. boulardii may also influence cellular signalling pathways common in many inflammatory conditions.
1568 in stock
Key Benefits
Widely studied for its effects on diarrhoea prevention
S. boulardii has been widely studied for its effects on diarrhoea prevention.
Clinically researched for its inhibitory effects on H pylori and C albicans
S. boulardii has been widely researched for it’s inhibitory effect on pathogens and parasites, including H. pylori and C. albicans
Rebalances the microbiome after antibiotic use
S. boulardii has been shown in studies to support the rebalancing of the gut microbiome, particularly following antibiotic use
Be the first to review “Bio.Me S. boulardii 60 Capsules”
Only logged-in users can leave a review.
Take 2 capsules daily.
Suitable from 6 months
Do not exceed the recommended dose, unless advised by your healthcare professional.
FAQs
Bio.Me S. boulardii can be taken with or without food at any time of the day.
If you are pregnant, breastfeeding, taking medication or under medical supervision, please consult your healthcare provider before using Bio.Me S. boulardii.
Probiotics are generally regarded as safe in pregnancy as the risk of them being absorbed into the bloodstream is very rare. However, Saccharomyces boulardii has not been specifically researched for its use in pregnancy and lactation yet. It is up to you as the practitioner to perform a risk-to-benefit analysis to decide if it is suitable for your client’s unique circumstances.
Bio.Me S. boulardii is suitable from 6 months.
Bio.Me S. boulardii is suitable for vegans.
There are no reviews yet.